Aruna Bio Announces Appointment of Mike Ryan to its Board of Directors BOSTON and ATHENS, Ga., Dec. 19, 2022 (GLOBE NEWSWIRE) -- Aruna Bio, Inc., a leader in the development of neural exosome-based therapeutics for the treatment of neurodegenerative diseases, today...

Aruna Bio Announces Presentation on Neural Exosome Treatment Opportunities and Lead Program, AB126 at Exosome Based Therapeutic Development Summit -AB126 is an unmodified exosome derived from neural stem cell lines with the innate ability to cross the blood-brain-barrier- -Preclinical data demonstrate the potential therapeutic activity of AB126...

Aruna Bio Closes $10.8 Million Common Stock Financing ATHENS, Ga. and RESEARCH TRIANGLE PARK, N.C., April 14, 2021 (GLOBE NEWSWIRE) -- Aruna Bio, Inc., a leader in the development of neural exosomes for the treatment of neurodegenerative diseases,...

Aruna Bio to Present at the Jefferies 2020 Healthcare Conference ATHENS, Ga. and RESEARCH TRIANGLE PARK, N.C., May 26, 2020 (GLOBE NEWSWIRE) -- Aruna Bio, Inc., a leader in the development of neural exosomes for the treatment of neurodegenerative diseases, today...